MA11.07 Pembrolizumab Plus Maintenance Olaparib as First-Line Therapy for Metastatic Nonsquamous NSCLC: Phase 3 KEYLYNK-006 Study
Jhanelle E. Gray, Michael Schenker, Mehmet Alı Nahıt Şendur et al. · Journal of Thoracic Oncology · 2024
Cited by 1 works. doi:10.1016/j.jtho.2024.09.178 Open-access PDF